Injective
Research.

Messari covers the accelerated growth of RWA perpetuals trading on Injective, on track to reach an annualized run rate of $6.5 billion by year-end.

Injective launches its native EVM layer, an unmatched development environment custom built to power the next generation of onchain finance applications.

Urges regulators to clarify that non custodial, over collateralized DeFi credit protocols operate as automated systems for over collateralized loans and should not fall under securities laws.

Messari covers the growth of RWA perpetuals on Injective, trading $1.68B in volume YTD

The Tokenized Asset Coalition covers Injective's performance for the first half of 2025 across trading metrics, RWA tokenization, institutional adoption, and developer activity.

Reviews key metrics for the first half of 2025 on Injective, including staking activity, adoption, network upgrades, and ecosystem growth.

Urges regulators to recognize that decentralized, non custodial code should not be treated as an exchange or broker dealer and supports a safe harbor with clear exemptions for neutral front ends.

An in-depth overview of Injective by 21Shares, covering the chain's architecture, Web3 modules, RWA tokenization suite, token economy, and more.

Explains how transaction flow and account structure work on Injective, and how wallets, signatures, and account types map to real activity on-chain.

Chorus One examines Injective's innovative approach to bringing RWAs onchain with enhanced capital efficiency and programmability

Covers how real world assets are issued and traded on Injective, opening the door for large scale institutional capital to move onchain.

The Stanford Blockchain Club covers how Injective is built for high performance, native financial primitives, and efficient onchain markets.